BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16622878)

  • 1. Hepatitis B virus mutations associated with antiviral therapy.
    Bartholomeusz A; Locarnini S
    J Med Virol; 2006; 78 Suppl 1():S52-5. PubMed ID: 16622878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression.
    Choi YM; Lee SY; Kim BJ
    World J Gastroenterol; 2018 Apr; 24(16):1708-1724. PubMed ID: 29713126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action.
    Mokaya J; McNaughton AL; Hadley MJ; Beloukas A; Geretti AM; Goedhals D; Matthews PC
    PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006629. PubMed ID: 30080852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and identification of compounds with antiviral activity against hepatitis B virus using a safe compound library and novel real-time immune-absorbance PCR-based high throughput system.
    Lamontagne J; Mills C; Mao R; Goddard C; Cai D; Guo H; Cuconati A; Block T; Lu X
    Antiviral Res; 2013 Apr; 98(1):19-26. PubMed ID: 23415884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus genetic mutations and evolution in liver diseases.
    Shen T; Yan XM
    World J Gastroenterol; 2014 May; 20(18):5435-41. PubMed ID: 24833874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Post-Transcriptional Regulatory Element of Hepatitis B Virus: From Discovery to Therapy.
    Mouzannar K; Schauer A; Liang TJ
    Viruses; 2024 Mar; 16(4):. PubMed ID: 38675871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coevolution analysis of amino-acids reveals diversified drug-resistance solutions in viral sequences: a case study of hepatitis B virus.
    Teppa E; Nadalin F; Combet C; Zea DJ; David L; Carbone A
    Virus Evol; 2020 Jan; 6(1):veaa006. PubMed ID: 32158552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations and mutations in the hepatitis B virus genome and their associations with clinical characteristics.
    Yano Y; Azuma T; Hayashi Y
    World J Hepatol; 2015 Mar; 7(3):583-92. PubMed ID: 25848482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in Pol gene of hepatitis B virus in patients with chronic hepatitis B before and after therapy with nucleoside/nucleotide analogues.
    Januszkiewicz-Lewandowska D; Rucka A; Kowala-Piaskowska A; Bereszynska I; Mozer-Lisewska I; Zajac-Spychala O; Wysocki J; Nowak J
    Acta Virol; 2014; 58(2):185-9. PubMed ID: 24957725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of hepatitis B virus S gene mutants in patients experiencing hepatitis B surface antigen seroconversion after peginterferon therapy.
    Hsu CW; Yeh CT
    Hepatology; 2011 Jul; 54(1):101-8. PubMed ID: 21503942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus resistance to nucleos(t)ide analogues.
    Zoulim F; Locarnini S
    Gastroenterology; 2009 Nov; 137(5):1593-608.e1-2. PubMed ID: 19737565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance.
    Croagh CM; Desmond PV; Bell SJ
    World J Hepatol; 2015 Mar; 7(3):289-303. PubMed ID: 25848459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phylogenetic Analysis and Emerging Drug Resistance against Different Nucleoside Analogues in Hepatitis B Virus Positive Patients.
    Gohar M; Rehman IU; Ullah A; Khan MA; Yasmin H; Ahmad J; Butt S; Ahmad A
    Microorganisms; 2023 Oct; 11(11):. PubMed ID: 38004634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative metabolomics unveils molecular changes and metabolic networks of syringin against hepatitis B mice by untargeted mass spectrometry.
    Jiang YC; Li YF; Zhou L; Zhang DP
    RSC Adv; 2019 Dec; 10(1):461-473. PubMed ID: 35492557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prevalence and Serological Association of Hepatitis D Virus Genotypes in Taiwan.
    Joseph K; Shabangu CS; Jang TY; Huang CF; Dai CY; Huang JF; Chuang WL; Yu ML; Wang SC
    Pathogens; 2021 Sep; 10(10):. PubMed ID: 34684176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and Genetic Characterization of Hepatitis B and D Viruses: A Multi-Site Cross-Sectional Study of People Who Use Illicit Drugs in the Amazon Region.
    Silva RJS; do Nascimento RS; Oliveira-Neto JAJ; Silva FQ; Piauiense JNF; Gomes CM; Pinheiro LML; Resque RL; Pinho JRR; Kupek E; Fischer B; Machado LFA; Martins LC; Lemos JAR; Oliveira-Filho AB
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COLD-PCR Method for Early Detection of Antiviral Drug-Resistance Mutations in Treatment-Naive Children with Chronic Hepatitis B.
    Phung TTB; Chu SV; Vu ST; Pham HT; Nguyen HM; Nguyen HD; Le NT; Nguyen DV; Truong PT; Vu VTT; Nguyen ATV
    Diagnostics (Basel); 2020 Jul; 10(7):. PubMed ID: 32708399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Untapped Potential: A Qualitative Study of a Hospital-Based Dengue Surveillance System.
    Sulistyawati S; Nilsson M; Ekasari MP; Mulasari SA; Sukesi TW; Padmawati RS; Holmner Å
    Am J Trop Med Hyg; 2020 Jul; 103(1):120-131. PubMed ID: 32394883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current progress in the prevention of mother-to-child transmission of hepatitis B and resulting clinical and programmatic implications.
    Jourdain G; Ngo-Giang-Huong N; Khamduang W
    Infect Drug Resist; 2019; 12():977-987. PubMed ID: 31118703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of hepatitis B virus
    Ababneh NA; Sallam M; Kaddomi D; Attili AM; Bsisu I; Khamees N; Khatib A; Mahafzah A
    PeerJ; 2019; 7():e6583. PubMed ID: 30867996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.